InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by BEAVER JOHN R, Chief Executive Officer. Officer active across 2 companies, notably BIOLASE, INC. In total, 7 disclosures have been published. Total volume traded: €142k. The latest transaction was filed on 30 November 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
554.794 shares
Series G Preferred Stock
SEC:0000899243-22-016094:0·
€27,89270,000 shares@ €0.398560.4% of flow
Common Stock
SEC:0001209191-21-067673·
Ideal exit: 27 Aug 2022 (T+270)
€27,89270,000 shares@ €0.398529.2% of flow
Common Stock
SEC:0001209191-21-067673:0·
Ideal exit: 27 Aug 2022 (T+270)
€18,28435,000 shares@ €0.522439.6% of flow
Common Stock
SEC:0001209191-21-052884·
Ideal exit: 17 May 2022 (T+270)
€18,28435,000 shares@ €0.522419.2% of flow
Common Stock
SEC:0001209191-21-052884:0·
Ideal exit: 17 May 2022 (T+270)
€24,64540,000 shares@ €0.6161100.0% of flow
Common Stock
SEC:0001209191-21-033957·
Ideal exit: 13 Feb 2022 (T+270)
€24,64540,000 shares@ €0.616125.8% of flow
Common Stock
SEC:0001209191-21-033957:0·
Ideal exit: 13 Feb 2022 (T+270)
7 of 7 declarations
About BEAVER JOHN R
John R. Beaver is President and CEO of BIOLASE, INC. He leads the company by defining the strategic vision and overseeing operations. John is responsible for growth and innovation, playing a key role in the development of new products and market expansion. His leadership is essential for ensuring the success of BIOLASE.
